ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION

ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION

Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E498-E498
Hauptverfasser: Rasoul, Saman, van't Hof, Arnoud, Clare, Robert, Atar, Dan, James, Stefan, Tanguay, Jean-Francois, Betriu, Amadeo, brogan, gerard, Giugliano, Robert, Newby, L. Kristin
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Angina pectoris
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60499-9